THOMPSON INVESTMENT MANAGEMENT, INC. – Neurocrine Biosciences, Inc. Transaction History
THOMPSON INVESTMENT MANAGEMENT, INC. portfolio value:
$691,000
portfolio value
THOMPSON INVESTMENT MANAGEMENT, INC. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.66% | -1.3K shares | -70K | $106.21 | 6.50K |
| Q2 2022 | share | 0.00% | 0 shares | 29K | $97.48 | 7.80K | |
| Q1 2022 | share | Increase | +6.84% | 500 shares | 110K | $93.75 | 7.80K |
| Q4 2021 | share | Increase | +5.41% | 375 shares | -43K | $84.63 | 7.30K |
| Q3 2021 | share | 0.00% | 0 shares | -9K | $95.91 | 6.93K | |
| Q2 2021 | share | Increase | +56.43% | 2.5K shares | 243K | $97.32 | 6.93K |
| Q1 2021 | share | 0.00% | 0 shares | 6K | $97.25 | 4.43K | |
| Q4 2020 | share | Increase | +18.77% | 700 shares | 66K | $95.85 | 4.43K |
| Q3 2020 | share | Increase | +9.71% | 330 shares | -56K | $96.16 | 3.73K |
| Q2 2020 | share | Increase | 0.00% | 3.4K shares | 415K | $122 | 3.4K |